×

Allergan trading at a zero pipeline valuation: Evercore's Umer Raffat

3:18 PM ET Tue, 10 Oct 2017

After being named Institutional Investor's 2017 number-one biotech analyst, Umer Raffat of Evercore ISI discusses his picks for the biotech and specialty pharma sector.